Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.8K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.8K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
1.1K
Seizures: Classification01:13

Seizures: Classification

2.5K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K
Epilepsy ll: Types01:22

Epilepsy ll: Types

15
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
15
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.8K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of neuronal activity in human centromedian nucleus during an auditory attention and working memory task.

NeuroImage·2024
Same author

Diagnostic Accuracy of Ambulatory EEG vs Routine EEG in Patients With First Single Unprovoked Seizure.

Neurology. Clinical practice·2023
Same author

Association Between Frailty and Antiseizure Medication Tolerability in Older Adults With Epilepsy.

Neurology·2022
Same author

The Concept of an Epilepsy Brain Bank.

Frontiers in neurology·2020
Same author

Validation of the Status epilepticus severity score (STESS) at high-complexity hospitals in Medellín, Colombia.

Seizure·2020
Same author

Art and psychogenic nonepileptic seizures.

Epilepsy & behavior : E&B·2020

Related Experiment Video

Updated: Apr 21, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

3.1K

Medicinal marijuana for epilepsy: a case series study.

Lady Diana Ladino1, Lizbeth Hernández-Ronquillo1, José Francisco Téllez-Zenteno1

  • 11Department of Medicine,Division of Neurology,Saskatchewan Epilepsy Program,University of Saskatchewan,Saskatoon,Canada.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|November 8, 2014
PubMed
Summary

Medicinal marijuana users with epilepsy are typically young, single males with drug-resistant epilepsy and psychiatric comorbidities. Most found marijuana effective for seizure control, though its exact impact is complex to determine.

More Related Videos

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

8.2K
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

748

Related Experiment Videos

Last Updated: Apr 21, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

3.1K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

8.2K
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

748

Area of Science:

  • Neurology
  • Psychiatry
  • Pharmacology

Background:

  • Epilepsy affects millions globally, with a subset experiencing drug-resistant forms.
  • Medicinal marijuana is increasingly explored for managing epilepsy and associated symptoms.
  • Understanding patient profiles and usage patterns is crucial for optimizing treatment.

Purpose of the Study:

  • To characterize the social, clinical, and usage patterns of medicinal marijuana among patients with epilepsy (PWEs).
  • To identify common profiles of PWEs who use medicinal marijuana.
  • To assess patient-reported effectiveness and side effects of medicinal marijuana.

Main Methods:

  • A descriptive study involving 18 patients with epilepsy prescribed medicinal marijuana from a Canadian adult-epilepsy clinic.
  • Data collected on demographics, epilepsy characteristics, psychiatric comorbidities, substance use, and marijuana usage patterns.
  • Patient-reported outcomes regarding seizure control, mood, and side effects were analyzed.

Main Results:

  • Medicinal marijuana users represented 2.2% of the epilepsy population (18/800).
  • The typical user was a young (mean age 30), single male (67%) with drug-resistant epilepsy (61%) and psychiatric comorbidity (61%).
  • Most patients (83%) had prior marijuana use; all reported perceived effectiveness for seizure control and mood, with minimal side effects.

Conclusions:

  • Patients with epilepsy using medicinal marijuana often share a profile: young, single males with drug-resistant epilepsy and psychiatric comorbidities.
  • While patients perceive significant benefits for seizure control and mood, concurrent use of other antiseizure medications complicates definitive efficacy assessment.
  • Further research is needed to elucidate the precise role and optimal use of medicinal marijuana in epilepsy management.